GRAS status ginger extract,EU novel food, FSMP compliance, CosIng listed, FDA dietary supplement GMP, global regulatory sourcing
文章标题
EU& US Market Access: Your Supplier Compliance Checklist for Ginger Extract (FSMP, GRAS, CosIng)
详情页描述
Navigating the regulatory landscape for ginger-based products is complex.This checklist details the essential certifications and listings (GRAS, Novel Food, CosIng) your Ginger Extract supplier must provide for seamless entry into food, supplement, and cosmetic markets in the US and EU.
Facebook收藏标签
#GRAS#NovelFood #CosIng #FDA #EUCompliance #MarketAccess #RegulatoryAffairs #GingerExtract #BlueEyesBiotech
文章正文
For brands launching products containing Ginger Extract in the United States or European Union, regulatory compliance is not a final step but a foundational sourcing parameter. The regulatory status of your raw material dictates your product’s category, allowed claims, and marketability. Therefore, a procurement professional’s first due diligence task is to verify the compliance portfolio of the Ginger Extract supplier.
In the United States, the regulatory path depends on the final product category. For dietary supplements, the Ginger Extract must be manufactured in a facility compliant with FDA GMP (21 CFR Part 111). For use in foods or beverages, a GRAS (Generally Recognized as Safe) status is typically required. Your supplier should be able to provide evidence supporting GRAS, either through an FDA GRAS Notice No Objection Letter or an independent expert panel determination.
The European framework is more segmented. For food supplements, Ginger Extract may fall under the Novel Food Regulation if a specific preparation or concentration is new to the EU market. A compliant supplier will have a detailed dossier ready to support your application. If the extract is for use in Foods for Special Medical Purposes (FSMPs), even stricter quality and documentation apply. For cosmetics, the ingredient should be listed in the CosIng database with approved functions.
The burden of proof increasingly falls on the brand. Thus, sourcing from a supplier that provides an “audit-ready” package—including GMP certificates, GRAS dossiers, detailed Specifications, and Certificates of Analysis—is a critical risk-mitigation strategy. This documentation is as vital as the Ginger Extract itself.
Blue Eyes Biotech Co., Ltd. designs its compliance framework to facilitate our clients’ market access. Our Ginger Extract is produced under strict GMP and supported by robust regulatory documentation tailored for major markets. We provide the precise documentation you need to satisfy regulators and retailers, transforming a complex hurdle into a streamlined process. Partnering with us means your Ginger Extract sourcing is built on a compliant foundation from day one.
Ensure your market entry is smooth. Source compliant Ginger Extract from Blue Eyes Biotech Co., Ltd. Contact us: [email protected], www.blueeyes-bio.com, WhatsApp: +66840769830.